Krystal Biotech, Inc. Operating Lease, Liability, Noncurrent
Krystal Biotech, Inc. (KRYS) had Operating Lease, Liability, Noncurrent of $7.04 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-03
- 2026-06-30: Operating Lease, Liability, Noncurrent $7.04M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $7.31M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $7.57M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $7.81M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $7.04M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $7.31M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $7.57M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $7.81M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $8.06M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $8.30M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $6.04M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $6.18M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $6.33M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $6.46M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $6.62M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $6.82M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $7.01M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $7.21M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $7.37M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $7.58M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $7.72M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $7.88M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $6.98M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $7.08M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $6.90M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.22M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.31M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $2.53M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.62M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.31M 10-Q · filed 2021-05-10 | $2.70M 10-Q · filed 2020-05-04 |
| 2020-01-21 | $10.00M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $2.78M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $2.86M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $2.93M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $2.98M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |